Evidence map›Paper›PMID 25125453›Full record

ArticleStatistical methods in medical research2017

Sample size determinations for group-based randomized clinical trials with different levels of data hierarchy between experimental and control arms.

Moonseong Heo, Alain H Litwin, Oni Blackstock, Namhee Kim, Julia H Arnsten

Abstract read
In one paragraph

Article in Statistical methods in medical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Moonseong Heo1 Department of Epidemiology and Population Health, Albert Einstein College of Medicine, NY, USA.
Alain H Litwin2 Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, NY, USA.
Oni Blackstock2 Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, NY, USA.
Namhee Kim4 Department of Radiology, Albert Einstein College of Medicine, NY, USA.
Julia H Arnsten1 Department of Epidemiology and Population Health, Albert Einstein College of Medicine, NY, USA.

Funding

Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI GOLDSTEIN, HARRIS · 2003 to 2013
$18.6M
Intensive Models of HCV Care for Injection Drug UsersR01DA034086 · NIDA · CLEMSON UNIVERSITY · PI LITWIN, ALAIN HARRIS · 2012 to 2016
$3.7M
HIV and Substance Abuse Clinical Addiction Research and Education (CARE) ProgramR25DA023021 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ARNSTEN, JULIA H. · 2007 to 2014
$2.7M
Development and Testing of an Adherence Intervention for HIV+ Women of ColorK23MH102129 · NIMH · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BLACKSTOCK, ONI J · 2014 to 2017
$739k
NCATS NIH HHS UL1 TR001073NIAID NIH HHS P30 AI051519NIDA NIH HHS R01 DA034086NIDA NIH HHS R25 DA023021NIMH NIH HHS K23 MH102129
6 · The paper itself

Abstract

We derived sample size formulae for detecting main effects in group-based randomized clinical trials with different levels of data hierarchy between experimental and control arms. Such designs are necessary when experimental interventions need to be administered to groups of subjects whereas control conditions need to be administered to individual subjects. This type of trial, often referred to as a partially nested or partially clustered design, has been implemented for management of chronic diseases such as diabetes and is beginning to emerge more commonly in wider clinical settings. Depending on the research setting, the level of hierarchy of data structure for the experimental arm can be three or two, whereas that for the control arm is two or one. Such different levels of data hierarchy assume correlation structures of outcomes that are different between arms, regardless of whether research settings require two or three level data structure for the experimental arm. Therefore, the different correlations should be taken into account for statistical modeling and for sample size determinations. To this end, we considered mixed-effects linear models with different correlation structures between experimental and control arms to theoretically derive and empirically validate the sample size formulae with simulation studies.

Indexed as

Linear ModelsSample SizeHumansRandomized Controlled Trials as TopicReproducibility of Resultsgroup-based interventionmixed-effects modelmulti-level datasample sizevarying sizes

Identifiers

PMID25125453
PMCPMC4329103

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.